首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
【24h】

Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

机译:散发性结直肠腺瘤中Ki-ras原癌基因突变和p53基因过表达与人口统计学和临床​​病理特征的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

In colorectal tumorigenesis, Ki-ras proto-oncogene mutation often occurs early in the adenoma-adenocarcinoma sequence, whereas mutation of the p53 gene is associated with late progression to carcinoma. We evaluated the relationship of demographic and clinicopathologic characteristics to Ki-ras mutation and p53 gene product overexpression in 1,093 baseline sporadic colorectal adenomas from 926 individuals enrolled in a phase III recurrence prevention trial. Ki-ras mutation was found in 14.7% of individuals and p53 overexpression was found in 7.0% of those tested. Multivariate analysis found older age, rectal location, and villous histology to be independently associated with Ki-ras mutation. Individuals with an advanced adenoma (>or=1 cm or high-grade dysplasia or villous histology) had a 4-fold higher likelihood of Ki-ras mutation [odds ratios (OR), 3.96; 95% confidence intervals (CI), 2.54-6.18]. Ki-ras mutations in codon 12 and of the G-to-A transition type were more frequent in older individuals, whereas G-to-T transversion was more frequent in rectal adenomas than in the colon. Multivariate analysis showed that previous history of a polyp (P = 0.03) was inversely associated with p53 overexpression. Large adenoma size (>or=1 cm), high-grade dysplasia, and villous histology were independently associated with p53 overexpression, with the strongest association for advanced adenomas (OR, 7.20; 95% CI, 3.01-17.22). Individuals with a Ki-ras mutated adenoma were more likely to overexpress p53 (OR, 2.46; 95% CI, 1.36-4.46), and 94.8% of adenomas with both alterations were classified as advanced (P
机译:在结直肠肿瘤发生中,Ki-ras原癌基因突变通常发生在腺瘤-腺癌序列的早期,而p53基因的突变则与晚期癌症相关。我们评估了人口统计学和临床​​病理特征与Ki-ras突变和p53基因产物过表达的关系,该研究来自926名参加III期复发预防试验的个人中1,093例基线散发性结直肠腺瘤。在14.7%的个体中发现Ki-ras突变,而在7.0%的个体中发现p53过表达。多变量分析发现,年龄较大,直肠位置和绒毛组织学与Ki-ras突变独立相关。患有晚期腺瘤(>或= 1 cm或高度不典型增生或绒毛组织学)的个体发生Ki-ras突变的可能性高4倍[奇数比(OR),3.96; 95%置信区间(CI),2.54-6.18]。年龄较大的个体中,密码子12和G-A过渡类型的Ki-ras突变更为常见,而直肠腺瘤中的G-T转化较结肠更为频繁。多变量分析表明息肉的既往史(P = 0.03)与p53过表达呈负相关。较大的腺瘤大小(>或= 1 cm),高度不典型增生和绒毛组织学与p53过表达独立相关,与晚期腺瘤最强相关(OR,7.20; 95%CI,3.01-17.22)。具Ki-ras突变腺瘤的个体更有可能过表达p53(OR为2.46; 95%CI为1.36-4.46),并且94.8%的腺瘤伴两种改变被归为晚期(P <或= 0.0001)。我们的大型横断面研究支持Ki-ras和p53在腺瘤进展中的作用,并显示它们的分子发病机制因解剖部位,年龄和黏膜易感性而异,如息肉的既往史所证明的那样。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号